Lasmiditan

Lasmiditan is a novel therapeutic drug used to treat acute migraine headaches. This drug is the first member of a new class of medications, called serotonin receptor agonists, which act on specific serotonin receptors in the brain and spinal cord. The serotonin receptors targeted by lasmiditan are believed to be involved in the pathophysiology of migraine, and it is thought that lasmiditan can reduce the intensity and duration of migraine attacks. It is also thought to have fewer side effects than existing migraine medications, such as triptans, making it an attractive option for treating acute migraine. Lasmiditan has recently been approved by the FDA for use in adults with migraine, and holds promise in providing an effective and safe treatment for this debilitating condition.